Sino Biopharmaceutica Company Insiders
SBHMY Stock | USD 9.05 0.00 0.00% |
Sino Biopharmaceutica employs about 25.6 K people. The company is managed by 10 executives with a total tenure of roughly 60 years, averaging almost 6.0 years of service per executive, having 2555.2 employees per reported executive. Break down of Sino Biopharmaceutica's management performance can provide insight into the company performance.
Ping Tse CEO CEO, Executive Director |
Fai Chia President Assistant to the President and Vice President |
Sino |
Sino Biopharmaceutica Management Team Effectiveness
The company has return on total asset (ROA) of 0.0451 % which means that it generated a profit of $0.0451 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2908 %, meaning that it generated $0.2908 on every $100 dollars invested by stockholders. Sino Biopharmaceutica's management efficiency ratios could be used to measure how well Sino Biopharmaceutica manages its routine affairs as well as how well it operates its assets and liabilities.Sino Biopharmaceutica Workforce Comparison
Sino Biopharmaceutical Ltd is currently regarded as top stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 25,569. Sino Biopharmaceutica totals roughly 25,552 in number of employees claiming about 100% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.29 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16. Sino Biopharmaceutical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Sino Biopharmaceutical Price Series Summation is a cross summation of Sino Biopharmaceutica price series and its benchmark/peer.
Sino Biopharmaceutica Notable Stakeholders
A Sino Biopharmaceutica stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sino Biopharmaceutica often face trade-offs trying to please all of them. Sino Biopharmaceutica's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sino Biopharmaceutica's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ping Tse | CEO, Executive Director | Profile | |
Fai Chia | Assistant to the President and Vice President | Profile | |
Wei Ye | Assistant President General Manager - R&D Department | Profile | |
Mingqin Li | Vice President Executive Director | Profile | |
Wun Tse | Assistant to the President | Profile | |
Hsin Tse | Vice President Executive Director | Profile | |
Zhoushan Tian | Executive Director | Profile | |
Cheung Cheng | Executive Vice Chairlady of the Board | Profile | |
Y Tse | Executive Chairlady of the Board | Profile | |
Eric Tse | CEO Director | Profile |
About Sino Biopharmaceutica Management Performance
The success or failure of an entity such as Sino Biopharmaceutical often depends on how effective the management is. Sino Biopharmaceutica management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sino management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sino management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutica is traded on OTC Exchange in the United States.
Please note, the imprecision that can be found in Sino Biopharmaceutica's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sino Biopharmaceutical Ltd. Check Sino Biopharmaceutica's Beneish M Score to see the likelihood of Sino Biopharmaceutica's management manipulating its earnings.
Sino Biopharmaceutica Workforce Analysis
Traditionally, organizations such as Sino Biopharmaceutica use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sino Biopharmaceutica within its industry.Sino Biopharmaceutica Manpower Efficiency
Return on Sino Biopharmaceutica Manpower
Revenue Per Employee | 1.1M | |
Revenue Per Executive | 2.7B | |
Net Income Per Employee | 571.7K | |
Net Income Per Executive | 1.5B |
Additional Tools for Sino Pink Sheet Analysis
When running Sino Biopharmaceutica's price analysis, check to measure Sino Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sino Biopharmaceutica is operating at the current time. Most of Sino Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sino Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sino Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sino Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.